TeVido BioDevices uses the innovative process of 3D bioprinting living human cells for use as implants or grafts for use in reconstructive surgery and wound care, for example in post-surgery care for cancer patients.

In this live webinar, Dr. Scott Collins will explain TeVido’s innovation journey, from concept, through research and prototying, to funding, patenting, and testing the company’s highly innovative offering in the field of biotechnology.


Scott Collins TeVido.jpg

Dr Scott Collins 

Scott is Chief Technology Officer and President of Research and Development at TeVido BioDevices and has 23 years expertise spanning from engineering, the life sciences and biodevices.